Dasatinib is a medication that is primarily used to treat specific types of leukemia and other blood cancers. It is an inhibitor of certain proteins located within cancer cells, thereby preventing the cells from dividing and multiplying, ultimately leading to their destruction. Other synonyms for dasatinib include Sprycel, which is the brand name for the medication, and BMS-354825, which is the chemical compound name. Dasatinib is also known as a tyrosine kinase inhibitor, or TKI, which is a type of medication that targets specific molecules within cancer cells to inhibit their growth. Overall, dasatinib is an important medication in the fight against various types of blood cancer, and it remains to be an active area of research for potential new treatments.